Tumor Vaccines Articles & Analysis
8 articles found
Alfa Cytology has introduced its advanced drug development services for brain tumors. Alfa Cytology, celebrated for its cutting-edge biotech solutions and extensive tumor research expertise, has recently introduced brain tumor drug development services, designed to empower researchers in understanding the intricacies and unique challenges ...
·Cell-Based Vaccines: Tumor cells or immune cells are modified to present the target antigens and stimulate an immune response. ...
Therefore, it can be well modified on its surface, such as coating with cell membrane, for the design and development of tumor vaccines. CpG is a type of oligodeoxynucleotide that can be used as an immune adjuvant to stimulate the maturation and development of antigen-presenting cells. CpG can be encapsulated with PLGA using the emulsion evaporation method. The ...
Immunotherapies harness the power of our immune system to better target and eliminate tumors; why is this an attractive option? What are the challenges? What solutions have been engineered so far? ...
Advances In CircRNA Research CircRNAs are currently relatively well studied in the field of tumor research. Studies have shown that circRNAs play critical roles in many aspects of multiple malignancies, such as cell cycle and proliferation, apoptosis, vascularization and invasion. Currently, it has been found that circRNAs can act as tumor antigens in immune ...
Background Tumor immunotherapies compose immune checkpoint inhibitors, therapeutic antibodies, tumor vaccines, cellular therapies, and so on. ...
But such vaccines are designed to treat cancer, not prevent it, and most need to be personalized to the set of neoantigens made in a given patient’s tumor, so even if the vaccines work, they are likely to be costly. ...
ByCalviri
Cancer therapy should aim to prevent recurrent disease. Surgery and toxic treatments remove only symptoms associated with cancer without trying to intervene in the aetiology, therefore the disease may recur. The autologous cancer vaccine supplemented with bio-modulation might fulfil requirements for effective tumour therapy. The autologous tumour vaccine is formed in the same way as our bodily ...